Aotus monkeys: their great value for anti-malaria vaccines and drug testing (Q34999470)

5 August 2017

1 reference

title

Aotus monkeys: their great value for anti-malaria vaccines and drug testing (English)

1 reference

5 August 2017

0 references

1 reference

1

Sócrates Herrera

1 reference

5 August 2017

Blanca Liliana Perlaza

series ordinal

2

1 reference

PubMed ID

12435447

5 August 2017

Anilza Bonelo

series ordinal

3

1 reference

PubMed ID

12435447

5 August 2017

Myriam Arévalo-Herrera

series ordinal

4

1 reference

5 August 2017

1 December 2002

1 reference

International Journal for Parasitology

5 August 2017

1 reference

5 August 2017

32

1 reference

5 August 2017

1625-1635

1 reference

5 August 2017

13

1 reference

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Reverse transcriptase-polymerase chain reaction amplification and partial sequence of T helper 1- and T helper 2-type lymphokine genes from the owl monkey (Aotus trivirgatus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Molecular insights into receptors used by malaria parasites for erythrocyte invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Host cell invasion by malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

South American monkeys in the development and testing of malarial vaccines--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

The China I/CDC strain of Plasmodium malariae in Aotus monkeys and chimpanzees.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. II. Development of Aotus vociferans as a model for testing transmission-blocking vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. I. Development in Aotus lemurinus griseimembra monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Adaptation of a strain of Plasmodium falciparum from a Montagnard refugee to Aotus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Efficacy trial of malaria vaccine SPf66 in Gambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Expression of cytokine genes in Aotus monkeys immunized with synthetic and recombinant Plasmodium vivax and P. falciparum antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Aotus New World monkeys: model for studying malaria-induced anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Humoral immune responses during a malaria vaccine trial in Tanzanian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Susceptibility of a New World Monkey to Plasmodium falciparum from Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Duffy Blood Group and Malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

The great primate debate

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Malaria DNA vaccines in Aotus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Susceptibility of Panamanian Aotus lemurinus lemurinus to sporozoite-induced Plasmodium falciparum (Santa Lucia) infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Two new species of night monkeys, genusAotus (Cebidae, platyrrhini): A preliminary report onAotus taxonomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Plasmodium: Experimental animals for human malaria and research needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunogenicity of Plasmodium falciparum sexual stage antigens: Implications for the design of a transmission blocking vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

The development of genetic tools for dissecting the biology of malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Leishmania braziliensis: development of primary and satellite lesions in the experimentally infected owl monkey, Aotus trivirgatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Strain specificity in the liver-stage development of Plasmodium falciparum in primary cultures of new world monkey hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A novel Plasmodium falciparum erythrocyte binding protein-2 (EBP2/BAEBL) involved in erythrocyte receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Schistosoma mansoni infection in owl monkeys (Aontus nancymai): evidence for the early elimination of adult worms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Flow cytometric analysis on reactivity of human T lymphocyte-specific and cytokine-receptor-specific antibodies with peripheral blood mononuclear cells of chimpanzee (Pan troglodytes), rhesus macaque (Macaca mulatta), and squirrel monkey (Saimiri sc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Large-scale production of Plasmodium vivax sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

The course of P. falciparum (Vietnam Oak Knoll strain) in Aotus trivirgatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey--model systems for basic biological and chemotherapeutic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Immunogenicity and Efficacy Trials in Aotus Nancymai Monkeys with Model Compounds Representing Parts of a 75-kD Merozoite Surface Antigen of Plasmodium Falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

An Effective Immunization of Experimental Monkeys Against a Human Malaria Parasite, Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Adaptation of the AMRU-1 strain of Plasmodium vivax to Aotus and Saimiri monkeys and to four species of anopheline mosquitoes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Sequence and diversity of T-cell receptor beta-chain V and J genes of the owl monkey Aotus nancymaae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Orthology between the genomes of Plasmodium falciparum and rodent malaria parasites: possible practical applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A class of potent antimalarials and their specific accumulation in infected erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Plasmodium vivax transmitted from man to monkey to man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

Reproducible infection of intact Aotus lemurinus griseimembra monkeys by Plasmodium falciparum sporozoite inoculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Nucleic acid vaccines against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Rationale for the development of an engineered sporozoite malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

Partial Protection of Plasmodium Falciparum-Vaccinated Aotus Trivirgatus against a Challenge of a Heterologous Strain *

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900191-1

7 January 2021

10.1016/S0020-7519(02)00191-1

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12435447